The $10.8 million in funding, led by S2G Ventures, will support the construction of a pilot plant in Singapore and the marketing of products globally
July 1, 2022
Avant, a biotechnology company and developer of an end-to-end platform for cell-cultivated fish and seafood, announced its over $10.8 million round led by S2G Ventures, the direct investment team of Builders Vision, an impact platform dedicated to building a humane and healthy planet.